2007
![](https://sparc.life/wp-content/uploads/2023/08/Sparc-Logo-1.jpg)
- Demerged from Sun Pharmaceutical Industries Limited
- SPARC listed on Bombay Stock Exchange and National Stock Exchange of India
2013
- US FDA approval received for LipodoxTM for treatment of ovarian cancer, multiple myeloma and AIDS related Kaposi’s sarcoma
![](https://sparc.life/wp-content/uploads/2023/10/Lipodox-Logo.jpg)
2014
![](https://sparc.life/wp-content/uploads/2023/10/Xelpros.jpg)
- US rights for XelprosR licensed to a subsidiary of Sun Pharma
2018
- US FDA approval received for Xelpros ® for the treatment of open-angle glaucoma or ocular hypertension
- USFDA approval received for ElepsiaTM as adjunctive therapy for the treatment of partial-onset seizures
![](https://sparc.life/wp-content/uploads/2023/08/Elepsia.jpg)
2019
![](https://sparc.life/wp-content/uploads/2023/08/bioprojet-150x150-2.jpg)
- Entered into licensing agreement with Bioprojet SCR to acquire exclusive rights for Vibozilimod
2020
- Entered into a worldwide license agreement for Vibozilimod with Sun Pharma
- Entered into a license agreement with Tripoint Therapeutics for ElepsiaTM
![](https://sparc.life/wp-content/uploads/2023/08/tripoin-1.jpg)
- New R&D facility set-up at Savli, Vadodara
![](https://sparc.life/wp-content/uploads/2023/08/Savli_2-768x512-1.jpg)
2021
![](https://sparc.life/wp-content/uploads/2023/09/visiox.jpg)
- Entered into license agreement with Visiox for PDP-716 (Brimonidine) and SDN-037 (Difluprednate)
![](https://sparc.life/wp-content/uploads/2023/09/Antibody-Icong-Our-History-Page-1.jpg)
- Entered into licensing agreement with Biomodifying for antibody (Anti MUC-1 antibody)
2022
- Entered into licensing agreement with SPI Inc. for SezabyTM (Phenobarbital sodium for Injection)
- Sezaby approved by USFDA under DESI guidelines
![](https://sparc.life/wp-content/uploads/2023/08/Sezaby.jpg)
2023
![](https://sparc.life/wp-content/uploads/2023/10/US-Office.jpg)
- Entered into licensing agreement to acquire exclusive rights for SCD-153
- Formation of US subsidiary